Doctor Stefan Mulverstedt
Bispebjerg University Hospital, Copenhagen (Denmark)
Treatment of Hypercholesterolaemia with PCSK9 Inhibitors in Denmark. Assessment of real-life data; Extent and Efficacy after the first years of clinical use
Event: ESC Congress 2019
Topic: Lipid-Lowering Agents
Session: PCSK9 inhibitors: from cells to patients
Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use.
Event: ESC Congress 2019
Topic: Lipid-Lowering Agents
Session: Preclinical pharmacotherapy
ESC 365 is supported by
